polylysine
Peptideexperimental
Polylysine refers to several types of lysine homopolymers, which may differ from each other in terms of stereochemistry and link position (α/ε). Of these types, only ε-poly-L-lysine is produced naturally. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2014 (NCT02078648)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPolylysine ↗
Also known as
- polylysine
- polylysine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06513546 | Phase 1/Phase 2 (Phase 2) | Oct 15, 2024 | PLL TX AUSTRALIA PTY LTD |
| NCT02078648 | Phase 1/Phase 2 (Phase 2) | May 1, 2014 | Stemline Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PLL TX AUSTRALIA PTY LTD | For profit | 1 | 1 | 1 | 2024 |
| Stemline Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1